Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Northwest Biothrputcs Inc (NWBO)

Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Northwest Biothrputcs Inc 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 USA

www.nwbio.com Employees: 25 P: 240-497-9024

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

Key Statistics

Overview:

Market Capitalization, $K 382,699
Enterprise Value, $K 396,029
Shares Outstanding, K 1,594,579
Float, K 1,556,309
% Float 97.60%
Short Interest, K 57,437
Short Float 3.61%
Days to Cover 5.71
Short Volume Ratio 0.34
% of Insider Shareholders 2.40%
% of Institutional Shareholders 0.04%

Financials:

Annual Sales, $ 1,380 K
Annual Net Income, $ -83,780 K
Last Quarter Sales, $ 200 K
Last Quarter Net Income, $ -26,830 K
EBIT, $ -82,370 K
EBITDA, $ -78,150 K

Growth:

1-Year Return -2.08%
3-Year Return -64.91%
5-Year Return -83.62%
5-Year Revenue Growth -42.74%
5-Year Earnings Growth -75.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -18.22 on 11/14/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -18.26
EPS Growth vs. Prev Qtr -182,100.00%
EPS Growth vs. Prev Year -91,000.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/26/12

NWBO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -313.92%
Profit Margin % -6,071.01%
Debt/Equity 0.00
Price/Sales 263.93
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.06
Interest Coverage -9.78
60-Month Beta -0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar